The Discounted Cash Flow (DCF) valuation of Abcellera Biologics Inc (ABCL) is (11.55) USD. With the latest stock price at 4.24 USD, the upside of Abcellera Biologics Inc based on DCF is -372.5%.
Based on the latest price of 4.24 USD and our DCF valuation, Abcellera Biologics Inc (ABCL) is a sell. selling ABCL stocks now will result in a potential gain of 372.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.1% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (29.41) - (7.19) | (11.55) |
| Upside | -793.7% - -269.5% | -372.5% |